Objective: The development of epilepsy has been linked to infections of the central nervous system, but recently also to infections and inflammation outside of the central nervous system. Thus we investigated the association between infections and the risk of subsequent epilepsy. Methods: This was a Danish nationwide population-based cohort study comprising a total of 1 938 555 individuals born between 1982 and 2012. Individuals were followed from birth until December 31, 2012, death, disappearance, emigration, or epilepsy diagnosis, whichever came first (28 512 666 person-years of follow-up). The exposure was hospital contacts for infection and the outcome was a diagnosis of epilepsy as recorded in the Danish National Hospital Register. Hazard ratios were calculated using Cox proportional hazards models adjusted for age, sex, calendar period, Apgar score, gestational age, birth weight, and parental history of epilepsy. Results: A total of 25 825 individuals received an epilepsy diagnosis during the study period, among whom 8235 (32%) had a previous hospital contact for infection. A hospital contact for infection was associated with a 78% increase in the risk of subsequently receiving an epilepsy diagnosis (hazard ratio 1.78, 95% confidence interval [CI] 1.73-1.83) compared with those without infection. The highest risk was observed after central nervous system infections (hazard ratio 4.97, 95% CI 4.42-5.59), but increased risks were identified across all infected organ systems and types of pathogens. The risk of receiving an epilepsy diagnosis was correlated with the temporal proximity of the infection (P < 0.001) and increased with the number of hospital contacts for infection (P < 0.001) and with the severity of infection (P < 0.001). Significance: The risk of receiving an epilepsy diagnosis was increased after a wide range of infections, suggesting that systemic inflammatory processes may be involved in the development of epilepsy.
| INTRODUCTION
Epilepsy is a major brain disease worldwide, with approximately 50 million individuals being affected. 1 It accounts for 0.6% of the global burden of disease and can severely impact the lives of persons with epilepsy through recurrent and unpredictable seizures, stigmatization, anxiety, depression, and premature death. 1, 2 Although some cases of epilepsy are believed to be largely genetic, others are classified as symptomatic, as they are secondary to trauma, stroke, tumors, or other identifiable factors. However, approximately half of epilepsy cases have no identifiable cause. 1, 3 Immunologic hypotheses about subgroups of epilepsy have gained growing attention in recent years, with several studies suggesting a connection between infections and the development of epilepsy. [4] [5] [6] [7] [8] Infection of the central nervous system (CNS), in particular, is a well-known risk factor for epilepsy and is considered "the main cause of seizures and acquired epilepsy in the developing world." 4 However, infections outside of the CNS can also harm the brain, for example, through induction of inflammatory responses affecting the brain, including the development of autoantibodies that can cross-react with brain antigens. [9] [10] [11] Indeed, immunologic and inflammatory processes, including CNSreactive autoantibodies, have been associated with various brain disorders, including epilepsy. 9, [12] [13] [14] [15] Recently, several specific infections have been associated with epilepsy, such as pertussis infection in children, 5 complicated influenza infections, 6 toxoplasmosis, 7 and various endemic infections, such as malaria, paragonimiasis, and toxocariasis. 8 However, large-scale studies investigating the role of a wide range of infections in the development of epilepsy have been lacking. We utilized the national Danish registers to investigate whether infections were associated with an increased risk of developing epilepsy.
| MATERIALS AND METHODS

| Data sources
The study was approved by the Danish Data Protection Agency and the Danish Health Data Authority. Data were analyzed anonymously and there was no contact with the participants. The study therefore did not need approval from the Committee on Health Research Ethics. We used data from the Danish Civil Registration System, the Danish National Hospital Register, and the Danish Medical Birth Registry. The Danish Civil Registration System contains information on every person living in Denmark since the system's establishment in 1968. 16 Data include date of birth, sex, disappearance, emigration, vital status, parental identity, and a 10-digit unique personal identification number, known as the CPR number, which enables individual-level linkage between the Danish registers. The Danish National Hospital Register was established in 1977 and records data from all inpatient admissions to Danish hospitals. 17 From 1995 onward, the register also includes information on outpatients and patients attending emergency departments. Thus, the term "hospital contact" was defined as either an inpatient admission, an outpatient contact, or an emergency contact. The Danish modification of the International Classification of Diseases, Eighth Revision (ICD-8), was used for diagnostic information until 1993; from 1994 onward, the Danish modification of ICD-10 was used. The Danish Medical Birth Registry contains information on all live births and stillbirths in Denmark from 1973, including data on gestational age, Apgar score, and birth weight. 18 
| Study population
Using the Danish Civil Registration System and the Danish Medical Birth Registry, we identified all individuals who were born in Denmark between January 1, 1982, and December 30, 2012 , who had at least 1 day of follow-up, and for whom the identity of the mother was known (n = 1 938 555). We prospectively followed all persons individually from the day they were born until they received a diagnosis of epilepsy or were censored due to one of the following events: death, emigration, disappearance, or December 31, 2012, whichever came first.
Key Points
• In this Danish nationwide cohort study, we followed 1 938 555 individuals from birth • A total of 25 825 individuals received an epilepsy diagnosis during the study period, among whom 8235 (32%) had a previous hospital contact for infection • A hospital contact for infection was associated with a hazard ratio for epilepsy of 1.78 (95% CI 1.73-1.83) compared with those without infection • An increased risk of epilepsy was present following infections in a wide range of different organ systems and of different pathogenic types • Infectious diseases may be involved in the development of epilepsy, possibly due to inflammatory processes affecting the brain
| Exposure: Assessment of infections
Patients with a primary diagnosis of infection in the Danish National Hospital Register were classified by organ system and pathogen type using ICD-8 and ICD-10 codes published previously (Table S1) . 19 Infections were grouped by organ system into the following groups: sepsis, hepatitis, gastrointestinal, skin, respiratory, urologic, genital, otitis media, and CNS. In addition, infections were grouped by pathogen type into 3 groups: bacterial, viral, and other pathogens. We used the first day of contact with an infection diagnosis as the date of onset of infection.
| Outcome: Assessment of epilepsy
Epilepsy was defined as having at least one hospital contact with an epilepsy diagnosis registered in the Danish National Hospital Register (ICD-8: 345 [except 345.29] and ICD-10: G40). Parents were identified using the Danish Civil Registration System, and parental epilepsy diagnoses were identified using the same codes in the Danish National Hospital Register. The ICD codes were also used to categorize epilepsy as either epilepsy with focal-onset seizures, epilepsy with generalized-onset seizures, or other or unspecified epilepsy. 
| Statistical analysis
Data management and data analyses were carried out using Stata, version 13 (StataCorp). We used Cox proportional hazards models to analyze the data. Proportionality was evaluated using log-log plots and Kaplan-Meier plots of predicted and observed values. A clustered sandwich estimator of variance was used to account for sibling pairs in the cohort. We used 2-sided significance tests and a 5% significance level throughout. Hazard ratios (HRs) were adjusted for age, sex, and calendar period in the basic model, 21 and further adjusted for Apgar score (≤7, >7), 22 gestational age (≥37, <37 weeks), 23 birth weight (≥2500, <2500 g), 23 and parental epilepsy (≥1 parent with an epilepsy diagnosis, 0 parents with an epilepsy diagnosis) 24 in the fully adjusted model. Age, calendar period, and infections were treated as time-dependent variables, whereas the remaining variables were treated as time-independent variables. Age was used as the underlying time scale in all analyses. Adjustment for sex was achieved by stratification. Calendar time was split into 6-year intervals and at January 1, 1994, and January 1, 1995, thereby taking into account the changes in the Danish National Hospital Register described earlier. When examining the effect of time since the most recent infection, the analysis was also adjusted for number of previous infections (0, 1, 2-4, or ≥5).
Unrealistic values of birth weight and gestational age were recoded as missing (a birth weight <500 g or >7000 g [n = 208] or a gestational age <22 weeks or >45 weeks [n = 570]).
For each individual, we identified the first of each type of infection and up to 8 successive infections. When counting days since the most recent infection, the time was restarted at zero for every new infection. To correct for the possibility that a single infection may have been recorded multiple times in the Danish National Hospital Register, we disregarded contacts that were not separated from the previous contact by a minimum of 7 days.
As the primary analysis, we investigated the association between having at least one hospital contact for infection and the risk of receiving an epilepsy diagnosis. Subsequently, we conducted several exploratory analyses: First, the risk of receiving an epilepsy diagnosis was examined for each organ system of the first infection and for the pathogen group of the first infection. We then explored the temporal association between infections and epilepsy diagnoses by examining how the risk of epilepsy varied with time passed since the most recent infection. In addition, we used the duration of inpatient admission for infection as a proxy for the severity of infection and analyzed the relationship between the severity of the first infection and the risk of receiving an epilepsy diagnosis. We calculated the risk of receiving an epilepsy diagnosis as a function of the number of previous hospital contacts for infection. When testing for trend in time since infection, number of infections, or duration of infections, the variable in question was included as a continuous parameter in the model.
| RESULTS
The cohort counted 1 938 555 individuals born in Denmark between 1982 and 2012, with a median follow-up of 14.6 years (first quartile: 7.1 years; third quartile: 21.9 years), yielding a total of 28 512 666 person-years of follow-up. During the study period, a total of 573 915 individuals had a hospital contact for infection without a previous epilepsy diagnosis. An epilepsy diagnosis was found in 25 825 individuals (1.3% of the cohort), of whom 8235 (32%) had a previous hospital contact for infection. Of the entire cohort, 59 859 individuals (3.1%) were censored before December 31, 2012 Table 1 .
Having at least one hospital contact for infection was associated with a 78% increased risk of receiving an epilepsy diagnosis (HR 1.78, 95% confidence interval [CI] 1.73-1.83) in the fully adjusted model when compared with individuals without infections. The risk of epilepsy after infection was increased similarly across the different ages at first infection ( Table 2) . We found no statistically significant difference between the sexes; women had an HR of 1.81 (95% CI 1.74-1.89), whereas men had an HR of 1.75 (95% CI 1.69-1.82; P = 0.20). The risk was higher for persons born from July 1, 1997, to December 31, 2012 (HR 1.91, 95% CI 1.81-2.02), than for persons born from January 1, 1982, to June 30, 1997 (HR 1.73, 95% CI 1.67-1.79).
CNS infection posed the highest risk of a subsequent epilepsy diagnosis, with an HR of 4.97 (95% CI 4.42-5.59), followed by sepsis (HR 3.01, 95% CI 2.49-3.66). However, except for genital infections, all sites of infection were associated with an increased risk of epilepsy, both when looking at the first infection (Table 3) and when comparing those ever infected in a particular organ system with those never infected in that organ system (Table S2) .
When investigating the types of pathogens of the first infection, we observed similarly elevated risks of receiving an epilepsy diagnosis when infections were classified as bacterial, viral, or other infections and compared with persons who had no hospital contact for any type of infection (Table 3 ). The same was true when comparing those ever infected with a particular pathogen with those never infected with that pathogen (Table S2) .
The temporal association between the most recent infection and the risk of a subsequent epilepsy diagnosis is presented in Figure 1 and Table S3 . The risk of epilepsy was highest shortly after the most recent infection, with an HR of 4.22 (95% CI 3.79-4.69) during the first month. The risk decreased with time after the most recent infection (P < 0.001) but remained significantly elevated for more than 10 years. We also studied the association between the risk of an epilepsy diagnosis and the time that had passed since the first infection-again the risk decreased with time passed since the first infection (P < 0.001; Table S4 ).
The risk of receiving an epilepsy diagnosis increased with the duration of the first inpatient admission for infection (P < 0.001; Figure 2 and Table S5 ), as well as with the cumulated duration of inpatient admissions for infection (P < 0.001; Table S6 ). The median duration of an individual's first inpatient admission for infection decreased from 4 days in 1982 to 1 day in 2012. The number of hospital contacts for infection was associated with an increased risk of epilepsy in a dose-response manner (P < 0.001; Figure 3 and Table S7 ). The highest risk of an epilepsy diagnosis was found after 8 or more hospital contacts for infection, with an HR of 5.52 (95% CI 4.71-6.48).
Although individuals with a parental history of epilepsy had a markedly increased risk of receiving an epilepsy diagnosis (HR 3.04, 95% CI 2.80-3.31), this did not modify the association between infection and epilepsy (P value for interaction = 0.39). Nonetheless, there was a superadditive effect of a parental history of epilepsy and exposure to infections, where individuals with the combination of exposure to infection and a parental history of epilepsy had an almost sixfold increased risk of epilepsy (HR 5.75, 95% CI 5.13-6.44). Table 1 ).
T A B L E 1 Baseline characteristics
When considering only inpatient admissions for infection, the HR for receiving an epilepsy diagnosis was virtually unchanged (HR 1.75, 95% CI 1.70-1.81). When excluding individuals who were registered with a diagnosis of epilepsy within 14 days of the first hospital contact for infection, the risk of epilepsy after infection was very similar to the overall risk estimate (HR 1.75, 95% CI 1.70-1.80). When restricting the analyses to 16 201 persons who had 2 or more diagnoses of epilepsy, the HR for epilepsy after a hospital contact for infection was 1.95 (95% CI 1.89-2.02). When including status epilepticus (ICD-8: 345.29, and ICD-10: G41) in our definition of epilepsy, the risk of an epilepsy diagnosis after hospital contact for infection did not change (HR 1.78, 95% CI 1.73-1.83).
In a sensitivity analysis, individuals were censored at the time of diagnosis of disorders known to increase the Table 1 ). The reference group consists of those without hospital contacts for infection. The data plotted in this figure are presented in Table S3 F I G U R E 2 Risk of epilepsy by duration of first inpatient admission for infection. Emergency and outpatient contacts for infection are not included. Adjusted for age, sex, calendar year, Apgar score, birth weight, gestational age, and parental epilepsy. A total of 49 001 individuals (2.5%), including 811 with epilepsy, were not included due to missing values (see Table 1 ). The reference group consists of those without inpatient hospital contacts for infection. The data plotted in this figure are presented in Table S5 8 . In this sensitivity analysis, having at least one hospital contact for infection was associated with an HR for receiving an epilepsy diagnosis of 1.68 (95% CI 1.63-1.74). An analysis of the association between time since the most recent infection and the risk of subsequent epilepsy showed that the temporal association was only negligibly weakened (Table S8) . Sensitivity analyses for specific types of epilepsy diagnoses showed that the risk of epilepsy with focal-onset seizures was higher (HR 1.97, 95% CI 1.87-2.07) than the risk of epilepsy with generalized-onset seizures (HR 1.66, 95% CI 1.56-1.76). For other or unspecified epilepsy, the HR was 1.87 (95% CI 1.81-1.93). When considering only non-CNS infections, the HR for epilepsy with focal-onset seizures was 1.88 (95% CI 1.79-1.97), for epilepsy with generalized-onset seizures the HR was 1.63 (95% CI 1.53-1.73), and for other or unspecified epilepsy the HR was 1.81 (95% CI 1.75-1.86).
| DISCUSSION
Few studies have looked into the association between a wide range of infections and the subsequent risk of epilepsy, but a number of studies have examined the risk of epilepsy after specific infections. A previous Danish register-based study looking specifically at Bordetella pertussis infections found a subsequent HR for epilepsy of 1.7 (95% CI 1.3-2.2), with higher risk for those with a longer duration of admission for infection and a similarly increased risk across different age groups of infections. 5 The risk of epilepsy after toxoplasmosis was systematically reviewed in an article from 2015, which reported a pooled odds ratio for epilepsy of 2.25 (95% CI 1.27-3.98). 7 A register-based study of influenza infections and bacterial superinfection found an increased risk of epilepsy with an odds ratio of 1.64 (95% CI 1.10-2.46), with the increased risk persisting 2 years after the infection. However, the odds ratio for epilepsy was only 1.12 (95% CI 1.03-1.22) for influenza when ignoring bacterial superinfections, hinting that the association may be linked to the severity of the infection. 6 The results from these studies of individual pathogens align with our results in terms of the direction and magnitude of the association. In our own study, the division of infections by pathogen was broad, which may account for the similarity of our estimates across pathogen categories. It is possible that a subset of infections within each category is responsible for the increased risks of epilepsy.
Our results indicate that the risk of being diagnosed with epilepsy is increased not only following CNS infections, but also following a broad range of peripheral infections. Peripheral infection may indirectly affect the brain through initiation of immunologic cascades and brain-reactive antibodies, 25, 26 thereby possibly increasing the risk of epilepsy. Infections and systemic inflammation can increase the permeability of the blood-brain barrier, [27] [28] [29] and it has been proposed that brain-reactive antibodies may reach the CNS and thereby damage the brain under conditions of compromised bloodbrain barrier function. 9 Furthermore, several epilepsy syndromes, including febrile infection-related epilepsy syndrome (FIRES), Rasmussen's syndrome, and limbic encephalitis, are thought to have immunologic or inflammatory pathogeneses or occur in patients following infection. 30, 31 Recent studies have demonstrated that infection also correlates with the development of several psychiatric disorders, such as schizophrenia and affective disorders, [32] [33] [34] which are common comorbidities in persons with epilepsy. 35, 36 Similar to our results in persons diagnosed with epilepsy, associations between infections and psychiatric disease have been demonstrated across various organ systems and pathogens, and are positively correlated with both temporal proximity and the number of infections. These findings indicate that the inflammatory processes occurring in response to peripheral infections may also harm the brain, possibly explaining the association with epilepsy and psychiatric morbidity alike.
| Strengths and limitations
The main strength of the present study is that it is a nationwide cohort study with prospectively collected data and F I G U R E 3 Risk of epilepsy by number of previous hospital contacts for infection. Adjusted for age, sex, calendar year, Apgar score, birth weight, gestational age, and parental epilepsy. A total of 49 001 individuals (2.5%), including 811 with epilepsy, were not included due to missing values of covariates (see Table 1 ). The reference group consists of those without hospital contacts for infection. The data plotted in this figure are presented in Table S7 that all individuals were followed from birth until the first epilepsy diagnosis. We had almost complete follow-up, as only 3.1% of the cohort emigrated, died, or disappeared. The study is not likely to have selection bias because all in-hospital treatment in Denmark is provided free of charge, and all citizens have free access to a primary care physician who may refer them to a hospital. Epilepsy diagnoses in the Danish National Hospital Register have been found by Christensen et al 20 to have a positive predictive value of 81% (95% CI 75%-87%). Christensen et al included status epilepticus in the definition of epilepsy, which we did not do in the current study. However, a sensitivity analysis in which we included status epilepticus in our definition of epilepsy showed that this did not alter our results. Furthermore, the positive predictive value of epilepsy diagnoses may be increased by requiring more than one registered diagnosis. 37 When we restricted our analyses to persons with 2 or more diagnoses of epilepsy, we found that the risk of an epilepsy diagnosis after infection increased even further, indicating that erroneous diagnoses did not explain the increased risk of epilepsy. The risk of epilepsy with focal-onset seizures was higher than for epilepsy with generalized-onset seizures. However, the positive predictive values of diagnoses of subtypes of epilepsy are low, 20 indicating that our analysis of subtypes of epilepsy may be less sensitive. Thus, any difference in risk associated with epilepsy subtype may be masked. Some patients may have been seen only by private neurologists and therefore would not appear in the hospital register; however, we believe that almost all epilepsy patients in Denmark have a hospital contact at some point that would capture the epilepsy diagnosis, either when the diagnosis was first made, at outpatient control visits, or at emergency contacts after a seizure. The only private epilepsy center in Denmark (Filadelfia, Dianalund, Denmark) is included in the Danish National Hospital Register. Furthermore, both primary and secondary diagnoses of epilepsy were used in this study, and the register allows for up to 20 diagnoses per contact, meaning that even when visiting the hospital for an unrelated reason, a diagnosis of epilepsy may be registered. The ICD-10 discharge codes for infections identify specific sites of infection with a high validity. A validation study found that the sensitivity of the ICD-10 diagnoses was 79.9% (95% CI 78.1%-81.3%), and the specificity was 83.9% (95% CI 82.6%-85.1%). 38 All individuals were followed from birth, and because we included individuals born after 1982 only (ie, after the establishment of the Danish Hospital Register in 1977), we have complete information on all hospital contacts for infection and epilepsy. Although this is a major strength of the present study, it also restricts the age of the participating individuals to a maximum of 31 years, which may limit the generalizability of the results to a younger population. However, the risk of receiving an epilepsy diagnosis was not associated with age at infection, suggesting that the increased risk may apply to older age groups as well. It is not likely that misclassification of acute symptomatic seizures in persons with infection as epilepsy contributed to the elevated risk of being diagnosed with epilepsy, since the analyses of temporal association show that the risk was elevated significantly even beyond 10 years after the hospital contact for infection. Furthermore, when we excluded all individuals who received an epilepsy diagnosis within the first 14 days after a hospital contact for infection, the association was only slightly attenuated. The association between infections and epilepsy remained after adjustment for major risk factors for epilepsy. A sensitivity analysis showed that even when taking into account the effect of head trauma, intracranial bleeding, stroke, intracranial tumors, cerebral palsy, and congenital malformations of the nervous system, the association between infection and a diagnosis of epilepsy was only slightly attenuated. The same was true for the temporal association. The association also remained when the analyses were restricted to include only inpatient admissions for infection, indicating that outpatient follow-up and emergency department visits did not affect our results. We found a higher risk of receiving an epilepsy diagnosis after infection in the latter half of the study period, which may be due to the inclusion of outpatient and emergency contacts increasing the completeness of epilepsy diagnoses in the register. However, in the overall estimate, this was adjusted for by adjusting for calendar year, and at the same time, we also adjusted for the decreasing duration of inpatient admissions over time. Nevertheless, we cannot rule out that the increased risk of being diagnosed with epilepsy after infections may be explained, partly or wholly, by other confounding factors for which we were unable to adjust. For instance, social or heritable factors associated with both the exposure and the outcome may exist. Because we did not have access to genetic information, we attempted to take heritable factors into account by adjusting for parental epilepsy diagnoses registered in the Danish National Hospital Register. However, adjustments for parental epilepsy and perinatal risk factors only modestly impacted the estimates. There was no statistically significant interaction between infection and parental epilepsy, but the combined effect of the 2 seemed to be superadditive, displaying an almost sixfold increased risk of epilepsy for persons exposed to both infections and parental epilepsy compared with persons without these exposures.
Our study uses infections registered in hospitals and therefore does not take into consideration less severe infections treated in general practice only. Therefore, the increased risk may not apply to more mundane infections not requiring hospital contact. Moreover, it is possible that the treatment of infection, rather than infection itself, is responsible for the increased risk of epilepsy, for example, penicillin is known to have epileptogenic properties when applied directly to brain tissue and is used in rats as an animal model for epilepsy. 39, 40 Penicillin can cross the blood-brain barrier 41 and may therefore contribute to the increase in epilepsy risk seen in individuals with infection. However, the risk of epilepsy was similarly increased after bacterial and viral infection, which indicates that the increase in risk was not attributable to antibiotic treatment. Finally, the risk of epilepsy was increased the most in temporal proximity to the infection but remained significantly elevated for more than 10 years after the infection, indicating that the association was not merely due to detection bias.
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